HS820 Unit 7 Mexico Seguro Popular Reform Case Study Example

Protection Before Access: A Unit 7 Case Study of Mexico's Seguro Popular From Its 2004 Launch to Its 2020 Replacement

[Student Name]

Purdue University Global

HS820: Global and National Health and Health Systems

Unit 7 Reform Case Study

[Instructor Name]

[Date]

The reform facts and sources cited are real; survey figures are rounded and labeled as approximate.

Background: A System Split by Employment

Before 2003, Mexico's health system was divided by where people worked. Formal private-sector employees were covered by the Mexican Social Security Institute, and public employees by their own institute, both funded by payroll contributions. Everyone else, about half the population, including farmers, informal workers and the self-employed, relied on services run by the Ministry of Health and state health departments, which were underfunded and charged fees, or paid private providers directly. Out-of-pocket payments made up roughly half of total health spending, and a large number of households each year faced catastrophic health expenditure (Frenk et al., 2006). The segmentation meant that public money per person was far higher for the insured than for the uninsured, even though the uninsured were poorer.

The Reform: How Money Moved

Seguro Popular was the everyday name for a scheme that a 2003 amendment wrote into the General Health Law, formally a system of social protection in health for families outside the payroll institutes. Its design rested on four mechanisms.

1. Enrollment: families without social security could enroll voluntarily, with premiums waived for the poorest income groups, which in practice meant most enrollees paid nothing.

2. Per-enrollee transfers: the federal government paid a fixed amount per enrolled family or person to state health services, with a smaller state contribution, so that funding followed enrollment rather than historical budgets.

3. A defined package: enrollees were entitled to a list of interventions, the Universal Catalog of Health Services, which grew from about 90 interventions at launch to more than 280 by the 2010s, with associated medicines.

4. A catastrophic fund: a separate national fund paid for high-cost conditions, such as childhood cancers, HIV treatment and neonatal intensive care, which state budgets could not absorb.

Enrollment grew from a few million people in 2004 to more than 50 million by the mid-2010s. Public spending on the previously uninsured rose substantially (Frenk et al., 2006).

Seguro Popular changed who paid for care far faster than it changed what care was available, and the evidence follows that gap.

The Evidence, Ranked by Design

The strongest early evidence comes from a matched-pair cluster randomized evaluation. Researchers paired 74 health clusters in seven states and randomly assigned one in each pair to receive encouragement to enroll and investment in facilities. After about ten months, households in treatment clusters had lower rates of catastrophic health spending, with the largest effects among the poorest households. The evaluation found no significant change in measured health outcomes, use of services or medication spending over that period (King et al., 2009).

The randomized design is the most credible in the case, but it has three limits. First, the follow-up was short; health outcomes such as control of chronic disease take years to change. Second, compliance was imperfect: some families in treatment clusters did not enroll and some in control clusters did, which dilutes the measured effect. Third, the evaluation covered seven states, which may not represent the poorest states where supply was weakest.

Observational studies using national household surveys over longer periods generally found reductions in catastrophic and impoverishing spending among enrolled households, with weaker and more mixed evidence on access and health outcomes. These studies are less certain than the trial because enrollment was voluntary and families who chose to enroll may not resemble families who stayed out.

Taken together, the evidence supports the first half of the claim strongly and the second half weakly. Seguro Popular reduced financial hardship; whether it improved health is unproven.

Financing Versus Delivery

The gap between financial protection and access has a structural explanation. Per-enrollee transfers gave states money, but they did not create clinics, doctors or medicines where none existed. In poorer southern states, the supply of facilities and staff grew more slowly than enrollment, and enrollees often found that the services in the package were not available nearby, or that medicines were out of stock. The reform changed the pooling and purchasing of care for the uninsured without changing, at the same pace, the delivery capacity that purchasing depends on. Health financing frameworks distinguish these functions for exactly this reason: a purchaser can pay only for care that providers are able to supply (Kutzin, 2001).

Replacement: A Second Test

Seguro Popular ended on the first day of 2020. Its successor, a federal institute called INSABI, dropped enrollment and the defined catalog altogether and pledged that anyone outside the payroll institutes could get care and medicines at no charge. That successor lasted barely three years: a 2023 law closed it and handed care of the uninsured to IMSS-Bienestar in the states that signed on.

National poverty measurement data from CONEVAL show that the share of the population reporting no access to health services rose from about 16 percent in 2018 to about 39 percent in 2022. Out-of-pocket spending also rose. This is consistent with the view that removing the defined package and per-enrollee funding reduced financial protection, but the period overlapped with the COVID-19 pandemic, which disrupted services everywhere and increased private spending. The replacement is a second natural experiment, but a confounded one, and the case treats its evidence as suggestive rather than decisive.

Lessons as Conditions

The case supports conditional lessons rather than verdicts.

First, insurance programs for the uninsured can reduce catastrophic spending quickly if they waive premiums for the poor, define an entitlement and fund catastrophic conditions separately. Second, they will improve access only where funding is matched by investment in facilities, staff and medicine supply, especially in the poorest regions. Third, removing an entitlement without a clear replacement can reverse gains in financial protection within a few years. Fourth, short randomized evaluations can measure financial effects but are poorly suited to measuring health effects, so programs should plan longer evaluations from the start.

Relevance to Other Systems

Countries extending coverage to informal workers face the same choice Mexico made: build a separate scheme for the uninsured or integrate them into existing social insurance. Seguro Popular kept the segmentation, giving the uninsured a parallel scheme with its own package and funding. That reduced hardship but left differences in benefits between the insured and uninsured populations, which critics argued entrenched a two-tier system.

Limits

The case relies on published evaluations and national survey data. It does not examine state-by-state variation in detail, which a fuller study would need, and figures from the replacement period may be revised.

References

Frenk, J., González-Pier, E., Gómez-Dantés, O., Lezana, M. A., & Knaul, F. M. (2006). Comprehensive reform to improve health system performance in Mexico. The Lancet, 368(9546), 1524-1534. https://doi.org/10.1016/S0140-6736(06)69564-0

King, G., Gakidou, E., Imai, K., Lakin, J., Moore, R. T., Nall, C., Ravishankar, N., Vargas, M., Téllez-Rojo, M. M., Hernández Ávila, J. E., Hernández Ávila, M., & Hernández Llamas, H. (2009). Public policy for the poor? A randomised assessment of the Mexican universal health insurance programme. The Lancet, 373(9673), 1447-1454. https://doi.org/10.1016/S0140-6736(09)60239-7

Kutzin, J. (2001). A descriptive framework for country-level analysis of health care financing arrangements. Health Policy, 56(3), 171-204. https://doi.org/10.1016/S0168-8510(00)00149-4